GGrantIndex
Sort

39,280 grants matching leukemia

NK Tolerance and Hematopoietic Cell Transplantation

$420,750
Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2009 · HL

MECHANISMS OF LYMPHOID CANCER-RELATED CHEMONEUROPATHY

$420,743
Patrick M Dougherty · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA

Epigenetic Control of Hematopoietic Stem Cells

$420,701
Christa E. Muller-Sieburg · Sidney Kimmel Cancer Center · R01 · FY2008 · DK

Regulation and Function of Cyclin D3 in B Cell Subsets

$420,663
Boston Medical Center · P01 · FY2005 · AI

Developmental Funds

$420,630
Anna Karolina Palucka · Jackson Laboratory · P30 · FY2024 · CA

T CELL TARGETING FOR GVHD

$420,615
University Of Minnesota Twin Cities · R37 · FY2004 · HL

Artemis: Biochemical ,structural and functional analysis

$420,540
Patricia Cortes · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · AI

GENETIC ANALYSIS OF GENES CONTROLLING A POSITION EFFECT

$420,406
Jasper D Rine · University Of California Berkeley · R37 · FY2006 · GM

Project 1: Biomarkers of Chemical Exposure and Leukemia Risk

$420,392
Patricia A Buffler · University Of California Berkeley · P42 · FY2008 · ES

Pathogenesis of ETV6-Related Acute Lymphoblastic Leukemia

$420,390
Kim Erika Nichols · St. Jude Children'S Research Hospital · R01 · FY2023 · CA

Cassette exons in neoplastic pro-B-cells: implications for immunotherapy

$420,362
Andrei Thomas-Tikhonenko · Children'S Hosp Of Philadelphia · U01 · FY2022 · CA

Arsenic Trioxide in Primary Curative APL Therapy

$420,352
Steven D Gore · Johns Hopkins University · R01 · FY2008 · CA

Regulation of hematopoietic stem cell self-renewal by GTPase activating protein signaling

$420,349
Marie-Dominique Filippi · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · DK

Elucidate and Modulate Cell Signaling in NK Cells for Glioma Treatment

$420,323
Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2020 · AI

Complement and T Cell Mediated Allograft Rejection

$420,281
Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · AI

Aberrant Megakaryopoiesis in the Myeloproliferative Neoplasms

$420,250
John D Crispino · Northwestern University At Chicago · R01 · FY2013 · HL

Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture

$420,235
Iannis Aifantis · New York University School Of Medicine · P01 · FY2019 · CA

Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture

$420,235
Iannis Aifantis · New York University School Of Medicine · P01 · FY2020 · CA

Augmenting Antitumor Immunity

$420,228
Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2012 · CA

Transcriptional Regulation of Innate-Like T Cells

$420,226
Albert S. Bendelac · University Of Chicago · R01 · FY2013 · AI

Deregulation of Cellular IkB Kinases by HTLV1 Tax

$420,218
Dean Ballard · Vanderbilt University · R01 · FY2007 · CA

Elucidate and Modulate Cell Signaling in NK Cells for Glioma Treatment

$420,175
Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2021 · AI

Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to

$420,112
Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA

Preclinical Diagnostic Imaging of Amyloid

$420,101
Jonathan S Wall · University Of Tennessee Knoxville · R01 · FY2011 · DK

Regulation of PMN activation by SLP-76, PRAM-1 and ADAP

$420,082
Gary A. Koretzky · University Of Pennsylvania · R01 · FY2007 · AI